Rafferty Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-43,693
| Closed | -$13.8M | – | 1102 |
|
|
2023
Q4 | $13.8M | Sell |
43,693
-4,667
| -10% | -$1.48M | 0.06% | 205 |
|
|
2023
Q3 | $8.18M | Buy |
48,360
+11,883
| +33% | +$2.01M | 0.05% | 280 |
|
|
2023
Q2 | $7.91M | Sell |
36,477
-1,478
| -4% | -$321K | 0.04% | 284 |
|
|
2023
Q1 | $6.89M | Sell |
37,955
-3,097
| -8% | -$563K | 0.05% | 297 |
|
|
2022
Q4 | $8.07M | Buy |
41,052
+13,226
| +48% | +$2.6M | 0.07% | 258 |
|
|
2022
Q3 | $6.26M | Sell |
27,826
-9,732
| -26% | -$2.19M | 0.07% | 274 |
|
|
2022
Q2 | $4.75M | Sell |
37,558
-14,416
| -28% | -$1.82M | 0.04% | 284 |
|
|
2022
Q1 | $6.59M | Buy |
51,974
+11,371
| +28% | +$1.44M | 0.04% | 296 |
|
|
2021
Q4 | $5.32M | Buy |
40,603
+14,433
| +55% | +$1.89M | 0.03% | 370 |
|
|
2021
Q3 | $3.2M | Buy |
26,170
+6,986
| +36% | +$854K | 0.02% | 440 |
|
|
2021
Q2 | $2.19M | Sell |
19,184
-8,710
| -31% | -$993K | 0.01% | 662 |
|
|
2021
Q1 | $3.35M | Buy |
27,894
+20,859
| +297% | +$2.51M | 0.02% | 419 |
|
|
2020
Q4 | $715K | Sell |
7,035
-13,284
| -65% | -$1.35M | 0.01% | 604 |
|
|
2020
Q3 | $1.57M | Buy |
20,319
+11,837
| +140% | +$915K | 0.02% | 485 |
|
|
2020
Q2 | $945K | Buy |
+8,482
| New | +$945K | 0.01% | 565 |
|